Global Hallux Valgus Treatment Market Share, Size, Research: By Type: Congenital Hallux Valgus, Juvenile or Adolescent’s Hallux Valgus, Tailer’s Bunion; By Treatment: Surgical and Mechanical treatment, Self-Care, Others; By Diagnosis; By Route of Administration; By Treatment Channel; Regional Analysis; Supplier Landscape; 2023-2031

Global Hallux Valgus Treatment Market Outlook

The growth of the global hallux valgus treatment market is driven by the rising number of rheumatoid arthritis cases, which was close to 35 million in 2021. Rheumatoid arthritis is among the major factors leading to hallux valgus. The overall market is likely to grow at a CAGR of 5.90% in the forecast period of 2023-2031 and the number of cases is likely to reach close to 38.3 million by 2030.

Key Company News

In May 2021, Zynrelef was approved by the U.S. Food and Drug Administration (FDA) and published by Heron Therapeutics. It is a dual action anaesthetic of bupivacaine-meloxicam with a sustained release mechanism for management of pain. Bupivacaine and low-dose meloxicam are combined in ZYNRELEF to overcome the challenges of inflammatory processes at the surgical site. A diffusion controlled Polychronomer® polymer forms the basis for ZYNRELEF's sustained controlled release of bupivacaine and meloxicam.

A marketing authorization was granted by the European Commission (EC) for ZYNRELEF to treat post-operative somatic pain of mild to moderate surgical wounds in adults in September 2020. Currently, ZYNRELEF is approved in 31 European countries, including the European Union and European economic area.

Introduction

One of the most common progressive deformities of the forefoot is hallux valgus, also known as bunion. Bunions are "bumpy" growths near the metatarsophalangeal (MTP) joint of the big toe. The development of these bunions and the consequent exacerbation and painful symptoms often occur when a person wears tight and narrow shoes. Apart from narrow shoes, factors like hereditary conditions, rheumatoid arthritis, and polio virus can also cause bunions.

Bunions can be classified clinically into mild, moderate, or severe bunions. Women and the elderly are among the most common patients of the condition, although it can happen to anyone.

Hallux valgus is easy to diagnose, based on the symptoms and the shape of the bump, but to get a better understanding, the doctor may suggest X-ray.

Two angles are widely accepted to study the condition. The intermetatarsal angle is the angle between the first and second metatarsal bones and if the angle is greater than 9 degrees, it is irregular and is called a metatarsus primus varus.

The hallux valgus angle is the angle of the big toe when the big toe is tilted towards the small toe. Angles greater than 15 degrees are considered to be the signs of hallux valgus.

The most important treatment option for bunions is surgery, which is more effective than self-management, pain relievers, and medical devices. A patient's treatment will, however, depend entirely on the severity of their condition.

Although non-surgical treatment would not fix the deformity, it will relieve symptoms to some extent. A physician may suggest surgery if the patient's pain persists despite all these measures.

According to the global hallux valgus treatment market research report, the market can be categorised into the following segments:

Market Breakup by Type

• Congenital Hallux Valgus

• Juvenile or Adolescent’s Hallux Valgus

• Tailer’s Bunion

Market Breakup by Treatment

• Surgical and Mechanical Treatment

• Self-Care

• Medications

• Devices

• Others

Market Breakup by Diagnosis

• X-Rays

• Medical History

• Physical Examination

• Radiography

• Others

Market Breakup by Route of Administration

• Oral

• Tablets

• Parenteral

• Injections

• Others

Market Breakup by Treatment Channel

• Public

• Private

Market Breakup by Region

• North America
  • United States of America
  • Canada
• Europe
  • United Kingdom
  • Germany
  • France
  • Italy
  • Others
• Asia Pacific
  • China
  • Japan
  • India
  • ASEAN
  • Australia
  • Others
• Latin America
  • Brazil
  • Argentina
  • Mexico
  • Others
• Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Nigeria
  • South Africa
  • Others

High Prevalence Rate of Bone Disease and Inflammatory Diseases, Rising Awareness About the Treatment, and Increased Investments on Research and Fundings are Key Market Trends

The increasing prevalence of bone diseases will contribute to growth of the market. In women, hallux valgus is more prevalent than in men, since pointed heels are commonly worn by women. Due to this, the internal and external soft tissues of the foot are ripped or unbalanced, increasing bone disease risk, leading to the growth of the hallux valgus treatment market.

Rapid rise in the prevalence of inflammatory diseases, such as rheumatoid arthritis, increases the risk of hallux valgus deformity, which in turn increases the demand for hallux valgus treatment.

Rising healthcare expenditure also influences the growth of the hallux valgus treatment market. The growth of the market can also be attributed to the increasing efforts by public and private organisations to spread awareness about the deformity and the availability of the treatment and effective therapies.

 
Factors like changing lifestyles of the population and the rapid rise in the population of working women are contributing to hallux valgus treatment market growth. The growth is also favoured by other factors like rise in consumer disposable income and elderly population.

New opportunities for market growth will also be stimulated by the increased investments and resources for research and development. The market will witness lucrative opportunities during the forecast period as there has been a significant rise in strategic partnerships. to develop cost-effective drugs and therapeutic solutions for hallux valgus treatment.

Strict FDA Regulations and Low Incomes to Obstruct the Market Growth

Strict regulations by FDA for medical device approvals are primarily responsible for impeding the expansion of the hallux valgus treatment market. Apart from strict regulations by the FDA, the market growth is also obstructed in the low-income countries by the high cost of the treatment, and lack of infrastructure.

Lack of awareness of the deformity as well as the lack of availability of treatment in some regions has been a major restraining factor for the growth of the market.

North America is Dominating the Hallux Valgus Treatment Market

The global market is dominated by North America in terms of market share and revenue and will continue to maintain its dominance during the forecast period as well. The leadership can be attributed to the higher presence of key players in the region, luxury lifestyles of women, and the rising mergers and acquisitions.

Rapid technological advancements are likely to make Europe the second leading region in the hallux valgus treatment market in the coming years.

Rising ageing population and an increase in paediatricians will drive the growth in the Asia Pacific market during the forecast period. In addition, better healthcare infrastructure and growing healthcare spending are expected to boost this region's market growth.

Therapeutic Landscape

For hallux valgus treatment, these devices are most commonly marketed across the globe:

PROstep Minimally Invasive Surgery System: Wright Medical Technology - PROstep is a minimally invasive surgery (MIS) technology developed by Wright Medical Technology. In order to preserve soft tissue, PROstep MICA and Minimally Invasive Foot and Ankle System are designed with the premise that any "current" procedure can be performed through smaller, less invasive incisions. This system consists of MICA screws, PROstep Burrs, PROstep power boxes, and instruments for minimally invasive procedures, such as Akin, Chevron, Bunionette, and Bunionectomy.

Magnezix CS: Syntellix - Magnezix is a magnesium alloy (MgYREZr) with stable metallic properties, but it is capable of being bioabsorbable and replaced by endogenous tissues in the body. Magnesium is considered an osteoconductive mineral and has an anti-infective effect, according to experimental studies.

Clinical Trials

Lapiplasty 3-dimensional plastic surgery is an advanced technology developed by Treace Medical Concepts for surgically correcting bunions. In addition to correcting all three dimensions of this bunion deformity problematic root, lapiplasty is the only procedure designed specifically for this problem.

Competitive Landscape

The report gives an in-depth analysis of the key players involved in the hallux valgus treatment market, sponsors manufacturing the drugs, and putting them through trials to get FDA approvals. The companies included in the market are as follows:

• Tornier N.V.

• Integra Life Sciences Holdings Corporation

• Wright Medical Technology, Inc.

• Smith & Nephew Plc

• Zimmer Biomet Holdings, Inc

• Arthrex, Inc.

• Stryker Corporation

• Ossur

• Biomet Inc

• OrthoHelix Surgical Designs

• Orthofix Holdings Inc

• Acumen

• Mondeal Medical System GmbH

• BioPro Inc

Key Highlights of the Report

*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.